Article Type
Changed
Tue, 08/31/2021 - 18:22

Key clinical point: Three-dimensional (3D) laparoscopic myomectomy for uterine fibroids has no additional surgical benefit compared with conventional two-dimensional (2D) laparoscopic myomectomy.

Major finding: There were no significant differences between the 3D and 2D groups in terms of operative blood loss (P = .421), change in serum hemoglobin levels (P = .553), and operative time (P = .344).

Study details: In a randomized controlled trial, 64 patients with symptomatic uterine fibroids were assigned either to 3D (n=32) or 2D (n=32) laparoscopic myomectomy.

Disclosures: No information on funding was available. The authors declared no conflict of interests.

Source: Song T and Kang DY. Eur J Obstet Gynecol Reprod Biol. 2021 Jul 23. doi: 10.1016/j.ejogrb.2021.07.036.

Publications
Topics
Sections

Key clinical point: Three-dimensional (3D) laparoscopic myomectomy for uterine fibroids has no additional surgical benefit compared with conventional two-dimensional (2D) laparoscopic myomectomy.

Major finding: There were no significant differences between the 3D and 2D groups in terms of operative blood loss (P = .421), change in serum hemoglobin levels (P = .553), and operative time (P = .344).

Study details: In a randomized controlled trial, 64 patients with symptomatic uterine fibroids were assigned either to 3D (n=32) or 2D (n=32) laparoscopic myomectomy.

Disclosures: No information on funding was available. The authors declared no conflict of interests.

Source: Song T and Kang DY. Eur J Obstet Gynecol Reprod Biol. 2021 Jul 23. doi: 10.1016/j.ejogrb.2021.07.036.

Key clinical point: Three-dimensional (3D) laparoscopic myomectomy for uterine fibroids has no additional surgical benefit compared with conventional two-dimensional (2D) laparoscopic myomectomy.

Major finding: There were no significant differences between the 3D and 2D groups in terms of operative blood loss (P = .421), change in serum hemoglobin levels (P = .553), and operative time (P = .344).

Study details: In a randomized controlled trial, 64 patients with symptomatic uterine fibroids were assigned either to 3D (n=32) or 2D (n=32) laparoscopic myomectomy.

Disclosures: No information on funding was available. The authors declared no conflict of interests.

Source: Song T and Kang DY. Eur J Obstet Gynecol Reprod Biol. 2021 Jul 23. doi: 10.1016/j.ejogrb.2021.07.036.

Publications
Publications
Topics
Article Type
Sections
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Article Series
Clinical Edge Journal Scan: Uterine Fibroid September 2021
Gate On Date
Fri, 08/27/2021 - 22:00
Un-Gate On Date
Fri, 08/27/2021 - 22:00
Use ProPublica
CFC Schedule Remove Status
Fri, 08/27/2021 - 22:00
Hide sidebar & use full width
render the right sidebar.
Conference Recap Checkbox
Not Conference Recap
Clinical Edge
Display the Slideshow in this Article
Medscape Article
Display survey writer
Reuters content
Disable Inline Native ads
WebMD Article